Literature DB >> 10694164

Seven-week interval between acquisition of a meningococcus and the onset of invasive disease. A case report.

K R Neal1, J S Nguyen-van-Tam, R C Slack, E B Kaczmarski, A White, D A Ala'Aldeen.   

Abstract

Invasive meningococcal disease (IMD) is thought to occur within a few days of pharyngeal acquisition of Neisseria meningitidis. During a longitudinal study of carriage and acquisition among 2453 first-year undergraduates we identified a male student from whom N. lactamica was isolated in October 1997 followed by N. meningitidis in December 1997. In mid-January 1998 this student suffered a mild episode of IMD (meningitis) during which N. meningitidis was isolated from his CSF. The meningococcus carried in December 1997 was phenotypically and genotypically indistinguishable from the invading organism, suggesting the possibility that the organism may have been carried for 7 weeks prior to the onset of invasive disease. Further studies are needed to assess more accurately the range of asymptomatic carriage prior to disease onset.

Entities:  

Mesh:

Year:  1999        PMID: 10694164      PMCID: PMC2810787          DOI: 10.1017/s0950268899003192

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  7 in total

1.  Carriage rate of Neisseria meningitidis among university students. Further data are needed.

Authors:  A Gilmore; J Stuart
Journal:  BMJ       Date:  2000-08-05

2.  Dynamics of meningococcal long-term carriage among university students and their implications for mass vaccination.

Authors:  D A Ala'Aldeen; K R Neal; K Ait-Tahar; J S Nguyen-Van-Tam; A English; T J Falla; P M Hawkey; R C Slack
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

3.  Evaluation of De-O-acetylated meningococcal C polysaccharide-tetanus toxoid conjugate vaccine in infancy: reactogenicity, immunogenicity, immunologic priming, and bactericidal activity against O-acetylated and De-O-acetylated serogroup C strains.

Authors:  P Richmond; R Borrow; J Findlow; S Martin; C Thornton; K Cartwright; E Miller
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

4.  Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection.

Authors:  R Borrow; N Andrews; D Goldblatt; E Miller
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

5.  The natural history of meningococcal carriage and disease.

Authors:  C L Trotter; N J Gay; W J Edmunds
Journal:  Epidemiol Infect       Date:  2005-10-20       Impact factor: 2.451

6.  Transcriptional profiling of Neisseria meningitidis interacting with human epithelial cells in a long-term in vitro colonization model.

Authors:  Ariann Hey; Ming-Shi Li; Michael J Hudson; Paul R Langford; J Simon Kroll
Journal:  Infect Immun       Date:  2013-08-26       Impact factor: 3.441

7.  Antibody persistence up to 5 y after vaccination with a quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine in adolescents.

Authors:  Beatriz P Quiambao; Ashish Bavdekar; Anand Prakash Dubey; Hemant Jain; Devayani Kolhe; Véronique Bianco; Jacqueline M Miller; Marie Van der Wielen
Journal:  Hum Vaccin Immunother       Date:  2017-02-02       Impact factor: 3.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.